PRODUCTS SERVICES COMPANY CONTACT FAQ

Search Dictionary Mobile

Login Register FREE

Cyclophosphamide (Cytoxan)

Subscribe to Selected New Research on Cyclophosphamide

14894 relevant articles (1608 outcomes, 2451 trials/studies) found for this Drug

Description: Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active ALDOPHOSPHAMIDE. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer.

Also Known As:

Cytoxan; Neosar; B-518; Cyclophosphamide Monohydrate; Cyclophosphamide, (+-)-Isomer; Cyclophosphamide, (R)-Isomer; Cyclophosphamide, (S)-Isomer; Cyclophosphane; Cytophosphan; Endoxan; NSC-26271; Procytox; Sendoxan; Monohydrate, Cyclophosphamide; 2H-1,3,2-Oxazaphosphorin-2-amine, N,N-bis(2-chloroethyl)tetrahydro-, 2-oxide

Relationship Network

Drug Context: Research Results

-

Organic Chemicals: 40

-

Hydrocarbons: 379

-

Halogenated Hydrocarbons: 28

-

Mustard Compounds: 3

-

Nitrogen Mustard Compounds: 1

-

Phosphoramide Mustards: 3

-

Cyclophosphamide: 14894

*

M-2 protocol: 5928

*

Ifosfamide: 2254

*

CAV protocol: 1546

*

CMF regimen: 751

*

EVAC protocol: 281

*

COPP protocol: 175

*

CHVP protocol: 123

*

perfosfamide: 120

*

mafosfamide: 114

*

VAP-cyclo protocol: 113

*

CPDD protocol: 96

*

CHOP-B protocol: 72

*

4-S-(propionic acid)sulfidocyclophosphamide: 70

*

CYVADIC protocol: 55

*

CEOP protocol 1: 53

*

trofosfamide: 53

*

CMFVP protocol: 39

*

PROMACE-CytaBOM protocol: 34

*

CMFP protocol: 31

*

VAB-IV protocol: 31

*

FMC protocol: 30

*

LSA2-L2 protocol: 30

*

Asta Z 7557: 23

*

4-hydroxycyclophosphamide: 21

*

CHOP protocol: 20

*

CISCA protocol: 18

*

MACOP-B regimen: 12

*

CAP protocol 2: 11

*

CEF regimen: 11

*

COP-B protocol: 11

*

BCVP protocol: 9

*

4-hydroxyperoxycyclophosphamide: 8

*

COP-BLAM protocol: 7

*

mafosfamide-lysine: 7

*

OPPA protocol: 7

*

*

AVCF protocol: 6

*

hexa CAF protocol: 6

*

MCOP protocol: 6

*

ANAVACYM protocol: 5

*

BFM 78 protocol: 5

*

CAF protocol: 5

*

CMFPT protocol: 5

*

COMF protocol: 5

*

*

ECHO protocol: 5

*

*

THP-COPBLM regimen: 5

*

VAB-6 regimen: 5

*

VAB-III protocol: 5

*

VACOP-B protocol: 5

*

ACE protocol 1: 4

*

CEOP-B protocol: 4

*

CTCb regimen: 4

*

LMB89 protocol: 4

*

MAC combination: 4

*

MACHO protocol: 4

*

MACOP-B protocol: 4

*

VAC protocol: 4

*

*

BEACOPP protocol: 3

*

BV-CAP protocol: 3

*

CAE-P protocol: 3

*

CBV protocol: 3

*

COPAC protocol: 3

*

*

LNH 87 protocol: 3

*

LNH-80 regimen: 3

*

PMitCEBO protocol: 3

*

4-hydroperoxydechlorocyclophosphamide: 2

*

4-ketocyclophosphamide: 2

*

ACVB protocol: 2

*

*

CMF-B protocol: 2

*

COMP protocol: 2

*

CVACE protocol: 2

*

D-CECaT regimen: 2

*

dechloroethylcyclophosphamide: 2

*

*

EMA-CO protocol: 2

*

M-BACOD protocol: 2

*

malmo protocol: 2

*

maphosphamide: 2

*

*

3-hydroxycyclophosphamide: 1

*

4-methylcyclophosphamide: 1

*

4-peroxycyclophosphamide: 1

*

5-chlorocyclophosphamide: 1

*

ACOPA II protocol: 1

*

AIEOP acute lymphoblastic leukemia protocol: 1

*

alcophosphamide: 1

*

ALL-BFM-95 protocol: 1

*

BCPP protocol: 1

*

Berlin-Frankfurt-Muenster protocol II: 1

*

BOP-CISCA-POMB-ACE regimen: 1

*

BVCPP protocol: 1

*

CAM combination: 1

*

CAMBO-VIP protocol: 1

*

CAMP protocol: 1

*

CCE protocol: 1

-

Organophosphorus Compounds: 126

-

Phosphoramide Mustards: 3

-

Cyclophosphamide: 14894

*

M-2 protocol: 5928

*

Ifosfamide: 2254

*

CAV protocol: 1546

*

CMF regimen: 751

*

EVAC protocol: 281

*

COPP protocol: 175

*

CHVP protocol: 123

*

perfosfamide: 120

*

mafosfamide: 114

*

VAP-cyclo protocol: 113

*

CPDD protocol: 96

*

CHOP-B protocol: 72

*

4-S-(propionic acid)sulfidocyclophosphamide: 70

*

CYVADIC protocol: 55

*

CEOP protocol 1: 53

*

trofosfamide: 53

*

CMFVP protocol: 39

*

PROMACE-CytaBOM protocol: 34

*

CMFP protocol: 31

*

VAB-IV protocol: 31

*

FMC protocol: 30

*

LSA2-L2 protocol: 30

*

Asta Z 7557: 23

*

4-hydroxycyclophosphamide: 21

*

CHOP protocol: 20

*

CISCA protocol: 18

*

MACOP-B regimen: 12

*

CAP protocol 2: 11

*

CEF regimen: 11

*

COP-B protocol: 11

*

BCVP protocol: 9

*

4-hydroxyperoxycyclophosphamide: 8

*

COP-BLAM protocol: 7

*

mafosfamide-lysine: 7

*

OPPA protocol: 7

*

*

AVCF protocol: 6

*

hexa CAF protocol: 6

*

MCOP protocol: 6

*

ANAVACYM protocol: 5

*

BFM 78 protocol: 5

*

CAF protocol: 5

*

CMFPT protocol: 5

*

COMF protocol: 5

*

*

ECHO protocol: 5

*

*

THP-COPBLM regimen: 5

*

VAB-6 regimen: 5

*

VAB-III protocol: 5

*

VACOP-B protocol: 5

*

ACE protocol 1: 4

*

CEOP-B protocol: 4

*

CTCb regimen: 4

*

LMB89 protocol: 4

*

MAC combination: 4

*

MACHO protocol: 4

*

MACOP-B protocol: 4

*

VAC protocol: 4

*

*

BEACOPP protocol: 3

*

BV-CAP protocol: 3

*

CAE-P protocol: 3

*

CBV protocol: 3

*

COPAC protocol: 3

*

*

LNH 87 protocol: 3

*

LNH-80 regimen: 3

*

PMitCEBO protocol: 3

*

4-hydroperoxydechlorocyclophosphamide: 2

*

4-ketocyclophosphamide: 2

*

ACVB protocol: 2

*

*

CMF-B protocol: 2

*

COMP protocol: 2

*

CVACE protocol: 2

*

D-CECaT regimen: 2

*

dechloroethylcyclophosphamide: 2

*

*

EMA-CO protocol: 2

*

M-BACOD protocol: 2

*

malmo protocol: 2

*

maphosphamide: 2

*

*

3-hydroxycyclophosphamide: 1

*

4-methylcyclophosphamide: 1

*

4-peroxycyclophosphamide: 1

*

5-chlorocyclophosphamide: 1

*

ACOPA II protocol: 1

*

AIEOP acute lymphoblastic leukemia protocol: 1

*

alcophosphamide: 1

*

ALL-BFM-95 protocol: 1

*

BCPP protocol: 1

*

Berlin-Frankfurt-Muenster protocol II: 1

*

BOP-CISCA-POMB-ACE regimen: 1

*

BVCPP protocol: 1

*

CAM combination: 1

*

CAMBO-VIP protocol: 1

*

CAMP protocol: 1

*

CCE protocol: 1